Growing burden of inflammatory bowel disease in China: Findings from the Global Burden of Disease Study 2021 and predictions to 2035
The burden of IBD in China is serious and increasingly severe. Establishing a comprehensive disease management system in China will help better control the medical burden of IBD.
Authors
- Xiaoyin Bai (ORCID: https://orcid.org/0000-0002-9092-7592)
- Ziqing Yu (ORCID: https://orcid.org/0000-0002-5530-359X)
- Yinghao Sun
- Hong Yang (ORCID: https://orcid.org/0000-0002-2986-7324)
- Qian Jiaming (ORCID: https://orcid.org/0000-0002-6252-7022)
- Gechong Ruan
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking Union Medical College Hospital (CN)
Publication Details
- Journal
- Chinese Medical Journal
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1097/cm9.0000000000003345
- Citations
- 34
- Primary Topic
- Inflammatory Bowel Disease
- Type
- article
- Field-Weighted Citation Impact
- 18.71
Funders
- National Natural Science Foundation of China
- Peking Union Medical College Hospital